ACEBLECY
LIVE

Serial Number

79301781

Owner

SANDOZ AG

Filing Date

Nov 10, 2020

Add to watchlist:

No watchlists yet
View on USPTO

ACEBLECY Trademark

Serial Number: 79301781 • Registration: 6399132

ACEBLECY is a trademark filed by SANDOZ AG on November 10, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

SANDOZ AG (208 trademarks)

VIADUKTSTRASSE 3
BASEL 4051 , CH

Entity Type: 03

NOVARTIS AG (7,165 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

November 10, 2020

Registration Date

June 29, 2021

Published for Opposition

April 13, 2021

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

CHANGE OF OWNER RECEIVED FROM IB
Jan 19, 2024 CHLD
NOTIFICATION PROCESSED BY IB
Aug 28, 2021 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Aug 10, 2021 FICS
FINAL DISPOSITION PROCESSED
Aug 10, 2021 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Jul 29, 2021 GPAR
REGISTERED-PRINCIPAL REGISTER
Jun 29, 2021 R.PR
NOTIFICATION PROCESSED BY IB
Apr 13, 2021 GPNX
PUBLISHED FOR OPPOSITION
Apr 13, 2021 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 24, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Mar 24, 2021 OP2R
NOTICE OF PUBLICATION
Mar 24, 2021 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 5, 2021 CNSA
ASSIGNED TO EXAMINER
Feb 23, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 19, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 15, 2021 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jan 14, 2021 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 7, 2021 REPR